Find your next paid study

Vega Therapeutics, IncNCT05776069

~$500 – $10,500

Actual pay is set by the research site.

Phase 1

A Phase 1 Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults

The goal of this clinical trial is to learn how ATI-105 administered to healthy participants at works in the body at different doses and with or without food. …

Friedreich AtaxiaCardiomyopathiesCentral Nervous System Diseases+4 more

Adjuvia Therapeutics, Inc.NCT07869654

~$500 – $10,500

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It is fatal. There is no treatment. People with GM1 are deficient in a certain enzyme.…

Lysosomal DiseasesGangliosidosisGM1

National Human Genome Research Institute (NHGRI)NCT03952637

~$150 – $2,700

Actual pay is set by the research site.

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

Primary: * To measure the rate of perioperative vulvovaginitis in a population of patients in central VA with non-malignant vulvar disease who require surgica…

VaginitisVulvar Diseases

University of VirginiaNCT06070454

Actual pay is set by the research site.

Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease

This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adult…

Actual pay is set by the research site.

HIV InfectionsSexually Transmitted Diseases

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV p…

Public Health Foundation Enterprises, Inc.NCT04855773

~$10 – $675

Actual pay is set by the research site.

UAB Cardiovascular Research Biobank

The UAB Cardiovascular Research Biobank (CARBON) will be a resource that contains biological materials, such as DNA samples, in addition to health and personal…

Natriuretic PeptidesCardiovascular DiseasesHypertension+2 more

University of Alabama at BirminghamNCT05067231

Actual pay is set by the research site.

Mixed Methods Study on Navigating Pregnancy and Parenthood With Lyme Disease

This is a mixed methods study exploring the experiences of pregnancy and parenting among participants with Lyme disease. Eligible participants will have been d…

Lyme DiseasePost Treatment Lyme DiseaseChronic Lyme Disease+4 more

Children's National Research InstituteNCT06397794

~$10 – $675

Actual pay is set by the research site.

CorEvitas Inflammatory Bowel Disease (IBD) Registry

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD…

Inflammatory Bowel Diseases

~$10 – $1,125

Actual pay is set by the research site.

CorEvitasNCT03162549

Eye DiseasesRetinal DiseaseGlaucoma+1 more

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adu…

Duke UniversityNCT06841575

Actual pay is set by the research site.

Phase 2

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis

RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis

Systemic SclerosisSclerodermaInterstitial Lung Diseases

Acute Kidney InjuryAcute Interstitial NephritisKidney Diseases

~$75 – $3,000

Actual pay is set by the research site.

Cabaletta BioNCT06328777

Biorepository to Support Research in Kidney Diseases

To support advances in the understanding of pathophysiology and therapies of kidney diseases by creating a BioBank of kidney tissue, DNA, plasma, and urine fro…